Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CARDAMYSTTM safely and effectively. See full prescribing information for CARDAMYSTTM. CARDAMYSTTM (etripamil) nasal sprayInitial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
CARDAMYST is indicated for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults.
- generic_name
- etripamil
- product_names
- etripamil
- ndc
- 83468-070, 83468-070-01, 83468-070-02, 83468-070-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en